Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor:: involvement of the M4 receptor subtype

被引:63
作者
D'Agostino, G
Bolognesi, ML
Lucchelli, A
Vicini, D
Balestra, B
Spelta, V
Melchiorre, C
Tonini, M
机构
[1] Univ Pavia, Sch Pharm, Dept Expt & Appl Pharmacol, I-27100 Pavia, Italy
[2] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy
[3] Gen Hosp Voghera, Div Urol, Pavia, Italy
[4] Univ Pavia, Dept Internal Med & Therapeut, Div Expt & Clin Pharmacol, I-27100 Pavia, Italy
关键词
muscarinic receptor antagonists; prejunctional muscarinic autoreceptors; H-3]-acetylcholine release; postjunctional muscarinic receptors; smooth muscle contraction; human detrusor;
D O I
10.1038/sj.bjp.0703080
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Experiments were carried out in human detrusor strips to characterize muscarinic receptor subtypes involved in the prejunctional regulation of acetylcholine (ACh) release from cholinergic nerve terminals, and in the postjunctional smooth muscle contractile response. 2 In detrusor strips preincubated with [H-3]-choline, electrical field stimulation (600 pulses) delivered in six trains at 10 Hz produced a tritium outflow and a contractile response. In the presence of 10 mu M paraoxon (to prevent ACh degradation) the tritium outflow was characterized by HPLC analysis as [H-3]-ACh (76%) and [H-3]-choline (24%). 3 Electrically-evoked [H-3]-ACh release was abolished by tetrodotoxin (TTX: 300 nM) and unaffected by hexamethonium (10 mu M), indicating a postganglionic event. It was reduced by physostigmine (100 nM) and the muscarinic receptor agonist, muscarone (10 nM-1 mu M), and enhanced by atropine (0.1-100 nM). These findings indicate the presence of a muscarinic negative feedback mechanism controlling ACh release. 4 The effects of various subtype-preferring muscarinic receptor antagonists were evaluated on [H-3]-ACh release and muscle contraction. The rank potency (-log EC50) orders at pre- and postjunctional level were. atropine greater than or equal to 4-diphenyl-acetoxy-N-piperidine (4-DAMP) > mamba toxin 3 (MT-3) > tripitramine > para-fluorohexahydrosiladiphenidol (pF-HHSiD) greater than or equal to methoctramine greater than or equal to pirenzepine > tripinamide, and atropine greater than or equal to 4-DAMP > pF-HHSiD >> pirenzepine = tripitramine > tripinamide > methoctramine >> MT-3, respectively. 5 The comparison of pre- and post-junctional potencies and the relationship analysis with the affinity constants at human cloned muscarinic receptor subtypes indicates that the muscarinic autoreceptor inhibiting ACh release in human detrusor is an M-4 receptor, while the receptor involved in muscular contraction belongs to the M-3 subtype.
引用
收藏
页码:493 / 500
页数:8
相关论文
共 35 条
  • [1] Muscarinic receptor subtype selective toxins
    Adem, A
    Karlsson, E
    [J]. LIFE SCIENCES, 1997, 60 (13-14) : 1069 - 1076
  • [2] ALBERTS P, 1995, J PHARMACOL EXP THER, V274, P458
  • [3] ANDERSON KE, 1993, PHARMACOL REV, V45, P253
  • [4] SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
    ARUNLAKSHANA, O
    SCHILD, HO
    [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01): : 48 - 58
  • [5] BOLDEN C, 1992, J PHARMACOL EXP THER, V260, P576
  • [6] Universal template approach to drug design: Polyamines as selective muscarinic receptor antagonists
    Bolognesi, ML
    Minarini, A
    Budriesi, R
    Cacciaguerra, S
    Chiarini, A
    Spampinato, S
    Tumiatti, V
    Melchiorre, C
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) : 4150 - 4160
  • [7] BRADING AF, 1993, RECONSTRUCTIVE UROLO, P15
  • [8] Caulfield MP, 1998, PHARMACOL REV, V50, P279
  • [9] CULLUMBINE H, 1955, Q J Exp Physiol Cogn Med Sci, V40, P309
  • [10] D'Agostino G., 1993, Life Sciences, V52, P580, DOI 10.1016/0024-3205(93)90377-F